Actively Recruiting

Phase Not Applicable
Age: 55Years - 80Years
All Genders
ID07005453

Diagnostic Performance and Sustainability of Using SCALE-EYE During Real-Time Colonoscopy

Led by Erasmus Medical Center · Updated on 2026-01-13

241

Participants Needed

3

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the diagnostic accuracy and environmental impact of a device called SCALE-EYE during colonoscopies for screening and surveillance of colorectal polyps. This study aims to compare SCALE-EYE's polyp size measurements with the standard biopsy-forceps method, while also assessing its potential to reduce the number of colonoscopies, waste, and carbon footprint. The study includes about 241 participants aged 55 to 80 who are undergoing screening or surveillance colonoscopy and have polyps smaller than 25 mm. Participants will have a colonoscopy where detected polyps are first measured by the endoscopist using optical assessment. Then, depending on the randomized group, the polyp size will be measured by SCALE-EYE and biopsy-forceps in different sequences. The study is multicenter, randomized, and endoscopist-blinded to maintain objectivity. Both SCALE-EYE and biopsy-forceps assisted measurements are used to determine the polyp size categorization. During the study, researchers will assess SCALE-EYE’s accuracy compared to biopsy-forceps measurements, its performance against optical assessment, and its learning curve based on measurement time and difficulty. They will also evaluate the agreement in surveillance intervals recommended by the different measurement methods. Safety will be monitored by tracking adverse events up to 30 days after colonoscopy. The study will also analyze sustainability factors such as reduction in colonoscopies and related environmental impacts.

CONDITIONS

Brief Title

Accuracy and Sustainability of SCALE-EYE Evaluation for Measuring Reliable Polyp Size

Who Can Participate

Age: 55Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants aged 55 to 80 years
  • Scheduled for fecal immunochemical test (FIT) screening or surveillance colonoscopy
  • Presence of colorectal polyps of all shapes smaller than or equal to 25 mm as assessed by the endoscopist
Not Eligible

You will not qualify if you...

  • No detected colorectal polyps or only diminutive hyperplastic rectal polyps (≤5 mm)
  • Inadequate bowel preparation (Boston Bowel Preparation Score less than 2 per segment)
  • Intraprocedural complications not caused by the study device
  • Known or suspected inflammatory bowel disease (IBD)
  • Polyposis syndromes such as serrated polyposis or familial adenomatous polyposis
  • Presence of ileoanal pouch and anastomosis
  • History of radiation or chemotherapy for colorectal lesions
  • Scheduled for therapeutic procedures like intervention for lower gastrointestinal bleeding, endoscopic mucosal resection (EMR), or endoscopic submucosal dissection (ESD)
  • Pregnancy
  • Unable to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - 1 day

Participants undergo a colonoscopy during which any detected colorectal polyps smaller than 25 mm are measured using optical assessment, SCALE-EYE, and biopsy-forceps assisted measurement in a randomized order.

1 procedure visit (in-person)

Long-term Monitoring

Duration - Up to 30 days post-colonoscopy

Participants are monitored for safety and sustainability outcomes including adverse events, surveillance interval agreement, and environmental impact up to 30 days after the colonoscopy.

1 follow-up visit or contact

Trial Site Locations

Total: 3 locations

1

Catharina Ziekenhuis

Eindhoven, North Brabant, Netherlands, 5623 EJ

Actively Recruiting

2

LUMC

Leiden, South Holland, Netherlands, 2333 ZG

Actively Recruiting

3

Erasmus MC

Rotterdam, South Holland, Netherlands, 3015 GD

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Similar Trials

A Multicenter, Placebo-controlled Clinical Study of Berberin...

Colorectal Adenoma

Actively Recruiting

1 location

Artificial Intelligence Predicts the Pathology and Endoscopi...

Colorectal Polyps

Actively Recruiting

1 location

Impact of a Digital Training Program (Colo-ID) on Optical Hi...

Colorectal Polyps

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here